ライフサイエンスコーパス: sentinel lymph node biopsy

1 a left lumpectomy with seed localization and sentinel lymph node biopsy.

2 e of adjuvant radiotherapy and the timing of sentinel lymph node biopsy.

3 over the efficacy of axillary dissection and sentinel lymph node biopsy.

4 000-microCi dose of I methylene blue dye for sentinel lymph node biopsies.

5 neoadjuvant chemotherapy could safely permit sentinel lymph node biopsy alone when the index node has

6 ymph-node biopsy plus axillary dissection or sentinel-lymph-node biopsy alone.

7 ruct surgeons in a standardized technique of sentinel lymph node biopsy and to educate those same sur

8 ine patients underwent lymphatic mapping and sentinel lymph node biopsy, and 10 had a positive axilla

9 One patient had a sentinel lymph node biopsy, and 8 patients underwent hea

10 underwent intraoperative lymphatic mapping, sentinel lymph node biopsy, and inguinal femoral lymphad

11 left shoulder underwent wide local excision, sentinel lymph node biopsy, and lymph node dissection.

12 ry nodal burden, deselection of patients for sentinel lymph node biopsy, and provision of radiotherap

13 y have implications for the potential use of sentinel lymph node biopsy as an alternative to axillary

14 Available evidence for the role of sentinel lymph node biopsy as it applies to conjunctival

15 been done to select appropriate patients for sentinel lymph node biopsy based on multiple prognostic

16 not only the indications and techniques for sentinel-lymph-node biopsy, but also lymph-node sampling

17 Sentinel lymph node biopsy can be associated with delays

18 Sentinel lymph node biopsy can be performed either befor

19 ngoing clinical trials will evaluate whether sentinel-lymph-node biopsy can be avoided altogether in

20 All patients underwent sentinel lymph node biopsy; completion lymphadenectomy w

21 Sentinel lymph node biopsy does not appear to have a sig

22 ng the appropriate selection of patients for sentinel lymph node biopsy, especially among patients wi

23 This review highlights the utility of sentinel lymph node biopsy for melanoma.

24 Patients who underwent thyroidectomy and sentinel lymph node biopsy for papillary thyroid cancer

25 section for staging has now been replaced by sentinel-lymph-node biopsy for patients with clinically

26 Digital images of sentinel lymph node biopsies from 56 patients with small

27 change in approach to patients with positive sentinel lymph node biopsies has increased the complexit

28 Sentinel-lymph-node biopsy has been embraced as a standa

29 The introduction of sentinel-lymph-node biopsy has brought new impetus to th

30 Sentinel-lymph-node biopsy has spread so rapidly that su

31 of the studies in the past 2 years regarding sentinel lymph node biopsy have been concerned with iden

32 Lymphatic mapping and sentinel lymph node biopsy have been established as defi

33 review suggested that these new methods for sentinel lymph node biopsy have clinical potential but g

34 Although details of methods for sentinel lymph node biopsy have yet to be standardised,

35 d in the decision about whether to perform a sentinel lymph node biopsy in 16% of patients (67 of 420

36 rge number of surgeons capable of performing sentinel lymph node biopsy in a standardized fashion wit

37 ce for the efficacy of lymphatic mapping and sentinel lymph node biopsy in predicting prognosis, redu

38 metastatic spread undermines the utility of sentinel lymph node biopsy in this condition.

39 It is now well established that sentinel lymph node biopsy is a powerful test to predict

40 Sentinel lymph node biopsy is a reasonable alternative t

41 Sentinel lymph node biopsy is performed as a standard pr

42 Sentinel-lymph-node biopsy is associated with increased

43 t findings, it seems reasonable to recommend sentinel lymph node biopsy or at least strict regional l

44 Therefore, it may be reasonable to consider sentinel lymph node biopsy or close nodal surveillance a

45 It may therefore be reasonable to consider a sentinel lymph node biopsy or strict regional lymph node

46 andomly assigned women with breast cancer to sentinel-lymph-node biopsy plus axillary dissection or s

47 ial mastectomy (PM), partial mastectomy with sentinel lymph node biopsy (PM SLNB), laparoscopic chole

48 elective lymph-node dissection, the role of 'sentinel' lymph-node biopsy, radiobiology and radiothera

49 ographic characteristics, trends in usage of sentinel lymph node biopsy, rates of local and distant r

50 Results Exercise and physical activity and sentinel lymph node biopsy reduce risk, and overweight a

51 s biopsy techniques could potentially render sentinel lymph node biopsy redundant in the future.

52 ecurrence of melanoma (16%) after a negative sentinel lymph node biopsy result was similar to that in

53 eased risk of recurrence, despite a negative sentinel lymph node biopsy result.

54 Sentinel lymph node biopsy (SLN) is an accepted alternat

55 There was a higher proportion of sentinel lymph node biopsies (SLNB) performed by high-vo

56 Observations: Sentinel lymph node biopsy (SLNB) after NAC in patients

57 y lymph node assessment (ALNA) consisting of sentinel lymph node biopsy (SLNB) alone if sentinel lymp

58 that disconcerting lymphedema rates in both sentinel lymph node biopsy (SLNB) and axillary lymph nod

59 oscintigraphy is standardly performed before sentinel lymph node biopsy (SLNB) for breast cancer.

60 Guidelines recommend sentinel lymph node biopsy (SLNB) for patients with clin

61 The validity of sentinel lymph node biopsy (SLNB) for T1 or T2, clinical

62 Indications for sentinel lymph node biopsy (SLNB) for thin melanoma are

63 evaluate the sensitivity and specificity of sentinel lymph node biopsy (SLNB) frozen section (FS) ex

64 Sentinel lymph node biopsy (SLNB) has become the gold st

65 after identification of nodal metastases by sentinel lymph node biopsy (SLNB) has been questioned.

66 iate clinical setting for the application of sentinel lymph node biopsy (SLNB) in the management of c

67 Sentinel lymph node biopsy (SLNB) is a newly developed m

68 Sentinel lymph node biopsy (SLNB) is an accurate, less i

69 Sentinel lymph node biopsy (SLNB) is being evaluated in

70 ent as clinically localized T1 melanoma, yet sentinel lymph node biopsy (SLNB) is controversial in th

71 Sentinel lymph node biopsy (SLNB) is currently the stand

72 Sentinel lymph node biopsy (SLNB) is the standard of car

73 500, and 800 sec/mm(2)), followed by either sentinel lymph node biopsy (SLNB) or axillary lymph node

74 ing regional lymph node evaluation by either sentinel lymph node biopsy (SLNB) or complete lymph node

75 ociated with lower- and higher-than-expected sentinel lymph node biopsy (SLNB) positivity rates and w

76 It has been validated that sentinel lymph node biopsy (SLNB) shows whether a patien

77 l recurrence rates of patients who underwent sentinel lymph node biopsy (SLNB) using radiocolloid gui

78 Sentinel lymph node biopsy (SLNB) was developed to repla

79 surgical axillary evaluation, categorized as sentinel lymph node biopsy (SLNB), axillary lymph node d

80 ospective pediatric melanoma database, using sentinel lymph node biopsy (SLNB), from 1992 to 2006, id

81 negative biopsy results underwent subsequent sentinel lymph node biopsy (SLNB), which yielded negativ

82 Final pathologic results (sentinel lymph node biopsy [SNB] or axillary lymph node

83 With the advent of sentinel lymph node biopsy, surgical methods for accurat

84 Most treatments, including sentinel lymph node biopsy, systemic therapy with taxane

85 Refinement of the sentinel-lymph-node biopsy technique might overcome the

86 ematic review to assess three techniques for sentinel lymph node biopsy that are not radioisotope dep

87 With the advent of sentinel lymph node biopsy, the axilla can be accurately

88 Sentinel lymph node biopsy use and 5-year cumulative inc

89 Sentinel lymph node biopsy was adopted for the staging o

90 A sentinel lymph node biopsy was performed in 23.3% of the

91 Sentinel lymph node biopsy was performed in 73.7% of whi

92 Sentinel lymph node biopsy was performed using an increa

93 Five hundred consecutive sentinel lymph node biopsies were performed using isosul

94 Sentinel lymph node biopsy will not identify metastases

95 inically and radiologically normal axilla is sentinel lymph node biopsy with a radioisotope and blue